Nanomaterial-based blood-brain-barrier (BBB) crossing strategies.
Xie J, Shen Z, Anraku Y, Kataoka K, Chen X.
Xie J, et al.
Biomaterials. 2019 Dec;224:119491. doi: 10.1016/j.biomaterials.2019.119491. Epub 2019 Sep 14.
Biomaterials. 2019.
PMID: 31546096
Free PMC article.
Review.
., relatively high drug loading content, controllable drug release, excellent passive and active targeting, good stability, biodegradability, biocompatibility, and low toxicity), nanomaterials with BBB-crossability have been widely developed for the treatment of CNS diseas …
., relatively high drug loading content, controllable drug release, excellent passive and active targeting, good stability, biodegrad …